Jinxin Fertility Group Limited
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a JXFGF research report →
Companywww.jxr-fertility.com
Jinxin Fertility Group Limited, an investment holding company, provides assisted reproductive services (ARS) in China and the United States. The company primarily offers two treatment solutions, including artificial insemination that is performed with either husband's sperm or a donor sperm; and IVF technology, whereby fertilization is achieved through conventional in vitro fertilization and embryo transfer or IVF with intracytoplasmic sperm injection. It also provides related services, such as nutrition guidance, Chinese medicine treatment, and psychological counseling to support the ARS.
- CEO
- Yang Dong
- IPO
- 2021
- Employees
- 3,198
- HQ
- Chengdu, CN
Price Chart
Valuation
- Market Cap
- $757.08M
- P/E
- -4.02
- P/S
- 2.01
- P/B
- 0.43
- EV/EBITDA
- 18.01
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 32.57%
- Op Margin
- 3.89%
- Net Margin
- -37.21%
- ROE
- -10.66%
- ROIC
- 0.77%
Growth & Income
- Revenue
- $2.58B · -8.21%
- Net Income
- $-950,955,721 · -435.91%
- EPS
- $-0.35 · -418.18%
- Op Income
- $197.94M
- FCF YoY
- -40.48%
Performance & Tape
- 52W High
- $0.50
- 52W Low
- $0.20
- 50D MA
- $0.29
- 200D MA
- $0.29
- Beta
- 0.81
- Avg Volume
- 737.004
Get TickerSpark's AI analysis on JXFGF
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our JXFGF Coverage
We haven't published any research on JXFGF yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate JXFGF Report →